[Andrey]

3.b. I talked about how it was akin to research expenditure and should be expensed

3.c. I talked about how future economic benefits are likely, technology feasible, and there are resources to take advantage of the drug in development. Therefore should capitalise development costs.

Rgarding $10 fee for drug payable to other company I just said this was going to be a normal costs. I think I was wrong

The biological asset with its cashflows and discounting screwed me up. i know hoe to value a biological asset = FV less costs to sell but the inflow/outflow of cash threw me

also what did people write for finding a FV for 150 vehicles?

[Author]

Posts